Distinct biological profiles associated with the risk of short-term relapse and mid/long-term relapse in Crohn's disease patients stopping infliximab

被引：0
|
作者：
Pierre, N. [1 ]
Huynh-Thu, V. A. [2 ]
Baiwir, D. [3 ]
Mazzucchelli, G. [4 ]
Fleron, M. [3 ]
Trzpiot, L. [4 ]
Eppe, G. [4 ]
Laharie, D. [5 ]
Satsangi, J. [6 ]
Colombel, J. F. [7 ]
Hertervig, E. [8 ]
Meuwis, M. A. [1 ]
Louis, E. [9 ]
机构：
[1] Univ Liege, Lab Translat Gastroenterol, Liege, Belgium
[2] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium
[3] Univ Liege, GIGA Prote Facil, Liege, Belgium
[4] Univ Liege, Lab Mass Spectrometry, Liege, Belgium
[5] Ctr Hosp Univ Bordeaux, Serv Hepatogastroenterol & Oncol Digest, Bordeaux, France
[6] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England
[7] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA
[8] Skane Univ Hosp, Dept Gastroenterol, Lund, Sweden
[9] Liege Univ Hosp, Hepatogastroenterol & Digest Oncol Dept, Liege, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP02
引用
收藏
页码：I3 / I6
页数：5
相关论文
共 50 条
  • [21] INFLIXIMAB IN CROHN'S DISEASE: LONG-TERM DURABILITY EXPERIENCE
    Dibb, M. J.
    Kemp, K.
    Johnson, C.
    Watson, A.
    Makin, A.
    Campbell, S.
    GUT, 2009, 58 : A94 - A95
  • [22] Long-Term Durability of Crohn’s Disease Treatment with Infliximab
    Stephen J. Rudolph
    David I. Weinberg
    Robert P. McCabe
    Digestive Diseases and Sciences, 2008, 53 : 1033 - 1041
  • [23] Infliximab in Crohn's disease: early and long-term treatment
    Armuzzi, A.
    De Pascalis, B.
    Fedeli, P.
    De Vincentis, F.
    Gasbarrini, A.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S271 - S279
  • [24] EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE
    Fries, W.
    Privitera, A. C.
    Lo Presti, M. A.
    Mastronardi, M.
    Cappello, M.
    Grossi, L.
    Lauria, A.
    Principi, M.
    Della Valle, N.
    Buccianti, N.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S134 - S134
  • [25] Long-term durability of Crohn's disease treatment with infliximab
    Rudolph, Stephen J.
    Weinberg, David I.
    McCabe, Robert P.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) : 1033 - 1041
  • [26] Establishment and Validation of Prediction Models for Short-term and Long-term Effectiveness of Ustekinumab in Patients with Crohn's Disease
    Su, T.
    Wu, H.
    Zhi, M.
    Yao, J.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1937 - I1938
  • [27] Short-Term Combination Therapy and Long-Term Relapse Prevention in the Treatment of Severe Acne Vulgaris
    Tan, Jerry
    Gold, Linda Stein
    Schlessinger, Joel
    Brodell, Robert
    Jones, Terry
    Cruz, Alma
    Kerrouche, Nabil
    Jarratt, Michael
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (02) : 174 - 180
  • [28] Crohn's disease of the ileoanal pouch treated with infliximab: Short term and long term outcomes
    MacLean, AR
    Zubaidi, AM
    Buie, WD
    Panaccione, R
    DISEASES OF THE COLON & RECTUM, 2006, 49 (05) : 757 - 757
  • [29] The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease
    Moss, A. C.
    Fernandez-Becker, N.
    Kim, K. Jo
    Cury, D.
    Cheifetz, A. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (02) : 221 - 227
  • [30] The TREAT registry data: Long-term safety of infliximab in patients with Crohn's disease
    Plotnick, Michael
    Turner, Michelle
    Lichtenstein, Gary R.
    Broussard, Delma L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB120 - AB120
12345